GlaxoSmithKline sued over risks associated with Avandia
A St. Tammany Parish resident has filed a lawsuit against GlaxoSmithKline for its alleged failure to warn about risks associated with the antidiabetic drug Avandia.
John Anderson and Connie Anderson filed suit on Dec. 21 in federal court in New Orleans.
GlaxoSmithKline is accused of misrepresenting, concealing and failing to disclose to physicians and patients, including John Anderson, information regarding the safety and effectiveness of Avandia.
Anderson took Avandia to treat his diabetes and states that the drug caused eye hemorrhages and a stroke on Aug. 20, 2011.
According to the complaint, Avandia can cause heart injury, excessive fluid retention, fluid-overload disease, liver damage, liver failure and severe injury to the heart leading to cardiac arrest and death.
The manufacturer is accused of knowing the drug could cause serious adverse health effects, but not adequately warning of the risks associated with the drug's use.
The plaintiffs are seeking damages for physical and mental pain and suffering, medical expenses, loss of quality of life, lost wages, lost earning capacity, loss of consortium, interest and court costs.
Anderson is represented by R. Glenn Carter and Amanda C. Graeber of Cater & Associates in New Orleans.
U.S. District Judge Sarah S. Vance is assigned to the case.
Case No. 2:11-cv-03135